Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.56−0.64 (-6.96%)
Close on Nov 18, 2026Market cap $764.38MP/E –Yield –
Syndax Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Syndax Pharmaceuticals's market cap was $854.95M on Nov 11, 2026, against $1.72B a year earlier. Over the last 5 years it ranged from $798.22M to $2.04B, with a median of $1.43B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $854.95M | -53.2% |
| 2025 | Dec 31, 2025 | $1.83B | +61.4% |
| 2024 | Dec 31, 2024 | $1.13B | -24.8% |
| 2023 | Dec 29, 2023 | $1.50B | -1.6% |
| 2022 | Dec 30, 2022 | $1.53B | +43.1% |
| 2021 | Dec 31, 2021 | $1.07B | +23.8% |
| 2020 | Dec 31, 2020 | $863.68M | +262.4% |
| 2019 | Dec 31, 2019 | $238.29M | +122.6% |
| 2018 | Dec 31, 2018 | $107.03M | -45.2% |
| 2017 | Dec 29, 2017 | $195.46M | +50.0% |
| 2016 | Dec 30, 2016 | $130.35M | – |
See a number that looks wrong?